Category: Vaccines
Vaccines market research reports by GlobalData
-
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
mRNA Vaccines in Infectious Diseases Market Overview Summary The report provides an assessment of the mRNA vaccines space, including History of mRNA Therapeutics Development, Industry Trends, Marketed Products, Pipeline Product, Opportunities, Challenges, and Unmet Needs, Current Companies and Brief ... Read More
-
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032 Summary Seasonal influenza (SI) is a contagious respiratory viral illness. There are four types of SI viruses: A, B, C, and D; however, only types A and B cause human disease of public health concern (WHO, 2023). Influenza transm ... Read More
-
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026 Summary The report provides an in-depth assessment of the COVID-19 market including disease ... Read More
-
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HPV Vaccines therapeutics. There will be more than 33 million vaccinations in ... Read More
-
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PV therapeutics. There will be more than 148 million vaccinations for PV in the adult p ... Read More
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in mpox therapeutics. In the 10 pharmaceutical markets covered in GlobalData’s epidemiology fact she ... Read More
-
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022 Summary This report contains a summary of the analyst consensus forecasts available in the GlobalData Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Currently ... Read More
-
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update Summary This 55-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Fin ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022 Summary The Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer looks at the data from clinical trials for vaccines and therapeutics either currently marketed or in the pipeline. The data is assessed, ... Read More
-
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030 Summary The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More
-
COVID-19 Cross-Sector Impact - Thematic Research (January 2022)
COVID-19 Cross-Sector Impact - Thematic Research (January 2022) Summary This report analyzes the impact of COVID-19 across industry sectors. It provides side-by-side analysis of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ acro ... Read More
Research Assistance
